166 related articles for article (PubMed ID: 2505732)
21. Localization of the neuronal class III beta-tubulin isotype in foci of early neuritogenesis supports divergent neuroblastic differentiation potential in Wilms' tumors.
Katsetos CD; Nakahara C; Agamanolis DP; Karkavelas G; Lebenthal E; Frankfurter A
Arch Pathol Lab Med; 1994 Oct; 118(10):1002-6. PubMed ID: 7944883
[TBL] [Abstract][Full Text] [Related]
22. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
[TBL] [Abstract][Full Text] [Related]
23. Differentiation in the medulloblastoma. A histological and immunohistochemical study.
Burger PC; Grahmann FC; Bliestle A; Kleihues P
Acta Neuropathol; 1987; 73(2):115-23. PubMed ID: 3604579
[TBL] [Abstract][Full Text] [Related]
24. Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation.
Tamura K; Shimizu K; Yamada M; Okamoto Y; Matsui Y; Park KC; Mabuchi E; Moriuchi S; Mogami H
Cancer Res; 1989 Oct; 49(19):5380-4. PubMed ID: 2504489
[TBL] [Abstract][Full Text] [Related]
25. Pale islands in medulloblastoma consist of differentiated cells with low growth potential.
Iijima M; Nakazato Y
Pathol Int; 1997 Jan; 47(1):25-30. PubMed ID: 9051689
[TBL] [Abstract][Full Text] [Related]
26. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
27. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
[TBL] [Abstract][Full Text] [Related]
28. Synaptophysin: a reliable marker for medulloblastomas.
Schwechheimer K; Wiedenmann B; Franke WW
Virchows Arch A Pathol Anat Histopathol; 1987; 411(1):53-9. PubMed ID: 3107209
[TBL] [Abstract][Full Text] [Related]
29. [Medulloblastoma with neuronal differentiation: a report of five cases].
Nishio S; Morioka T; Inamura T; Takeshita I; Ishihara S; Fukui M
No To Shinkei; 2000 May; 52(5):391-7. PubMed ID: 10845206
[TBL] [Abstract][Full Text] [Related]
30. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
31. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of four human medulloblastoma-derived cell lines.
Keles GE; Berger MS; Srinivasan J; Kolstoe DD; Bobola MS; Silber JR
Oncol Res; 1995; 7(10-11):493-503. PubMed ID: 8866661
[TBL] [Abstract][Full Text] [Related]
35. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.
Rodriguez FJ; Scheithauer BW; Robbins PD; Burger PC; Hessler RB; Perry A; Abell-Aleff PC; Mierau GW
Acta Neuropathol; 2007 Mar; 113(3):313-24. PubMed ID: 17061076
[TBL] [Abstract][Full Text] [Related]
36. Neuronal and glial proteins in medulloblastomas. II. Heterotransplantation of human medulloblastoma.
Sawa H; Takeshita I; Kuramitsu M; Egami H; Fukui M; Sato Y
Anticancer Res; 1986; 6(5):911-5. PubMed ID: 3099631
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas].
Korshunov AG; Sycheva RV; Golanov AV
Arkh Patol; 1998; 60(4):8-14. PubMed ID: 9791689
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
39. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
[TBL] [Abstract][Full Text] [Related]
40. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.
McManamy CS; Pears J; Weston CL; Hanzely Z; Ironside JW; Taylor RE; Grundy RG; Clifford SC; Ellison DW;
Brain Pathol; 2007 Apr; 17(2):151-64. PubMed ID: 17388946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
